News
Axon Ligands Catalogue Winter 2011 is available. [e-catalogue in pdf]
New Milestone Payment for Axon Biochemcials (Nov 2009). Axon Biochemicals BV, a partner company of Axon Medchem, received new milestone payment from H. Lundbeck A/S alone the clinical development of novel dopaminergic agent. Read more... (click)
"No News Is Good News" (May 2009; revised on Nov 2009). There is no news announced about Axon Medchem for more than a year, however, there is no decrease of our efforts in developing a research-oriented business. In fact, our services and Axon Ligands (TM) are drawing attention of life science researchers around world rapidly and widely. We are delighted to see many prestigious organizations among our valued customers, including most of top 50 ranking pharma companies in the world and top 10 ranking biomedical research institutes in USA. It is our commitment to meet researcher's need and build up a prime source of highest performance and up-to-date research reagents.
Axon Ligands Online Soon (Sept, 2007, Groningen). Axon Medchem BV will release its collection of ligands of interest in medicinal chemistry research very soon. Featured compounds will appear online as show cases.
Prominent Scientist As Consultant Of Axon Medchem BV (April, 2007). It is our great pleasure to announce that Prof dr. Henk Timmerman (LACDR, Amsterdam) agreed to be a consultant of Axon Medchem BV. We believe that Prof Timmerman will broaden our scientific and business visions in depth with his successful achievements in pharmaceutical chemistry research.
Axon Medchem Launched As A New Chemistry Service Platform (Jan 2007). Axon Medchem BV, a spin-off company of Axon Biochemicals BV, is in business operation in Groningen, The Netherlands, to take over and extend the chemistry service activities. Naturally, we are not new but experienced chemists specializing in contract research on drug design and synthesis. At the mean time, Axon Biochemicals BV will focus on its drug research and discovery programs. Read more |
![]() |
New Ligands
GDC0980 AZ960 SA4503 MG149
TG003 D-Atazanivir SCH530348 PNU100480 BVT2733 HMR1098
CoPo22 GSK1120212
CDDO-Me ICG001 Bazedoxifene
D106669 A770041 hCPT MK0354
PF3845 BMS345541 SB242084
WAY208466 Kifunensine BI6727
A83-01 P529 GB83 GSK690693
AV951 AC220 SLV319 REP3123
BXL628 FR180204 OSI906
STF083010 BIX01294 SU5402
PF02341066 CYT387 GSK461364
MK2206 Y27632 BINA Danoprevir
PD173074 TWS119 SCIO469
PHA408 CP547632 A357300
Perifosine Thiazovivin NN414
YM155 AZ3146 AZ23 AEB071
NSC23766 CHIR124 PF573228
XMD8-92 Ruxolitinib OSI420
SGI-1776 CDIBA PF4708671
HMR1031 KU0060648 MDV3100
Cilomilast AG7088 PS1145
GSK650394 CP466722 AG014699
SSR504734 BI-D1870 Osanetant
PD0332991 GDC0879 MK1775
LDN193189 MK0524 PD0220245
LY2157299 Parogrelil Stobadine
Secretase inhibitors DBZ BZ
VU0152100 CPPHA NS11394
Radiprodil KW6002 Ko143 TP003
SB612111 CP101606 CT99021
LY333531 R406 & more
Axon Medchem is presented at the 6th Workshop on Innovative Mouse Models (IMM2011), held on 12/13-May-2011, in Leiden NL. |